American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 24-27, January 2011

Metastasis to head and neck area: a 16-year retrospective study

  • Soussan Irani, MS

      Affiliations

    • Corresponding Author InformationDepartment of Oral and Maxillofacial Pathology, Hamadan University of Medical Sciences, P.O. Box: 365, Hamadan 65174-59114 Iran. Tel.: +98 811 8354016, 8354140, 0912 370 8936 (Mobile); fax: +98 811 8354220.

Received 9 August 2009 published online 23 December 2009.

Article Outline

Abstract 

Purpose

One of the most striking qualities of cancer is its spread throughout the body. The location of a metastatic mass may help to identify the primary tumor. Metastases to head and neck area can occur either from local structures or from distant organs.

Materials and methods

This study was a retrospective review of patients from a University Hospital in Tehran, Iran, during the period 1992 to 2008. The data were analyzed for sex, age, primary site of tumors, metastatic site, and histology of the tumors. The tumors were classified into 2 groups: intraoral and extraoral.

Results

A total of 191 cases were found; of these, 118 (62%) were men and 73 (38%) were women. The most common intraoral primary site was tongue (anterior and posterior parts). Thyroid gland was the most frequent primary extraoral site. The most frequent metastatic site was the lymph node, and level II most commonly involved lymph nodes, followed by level I.

Conclusion

Metastases are an infrequent finding in head and neck region and they may represent the initial manifestation of the disease. Diagnostic evaluation of metastatic lesion will detect the primary tumor.

 

Back to Article Outline

1. Introduction 

One of the most striking qualities of cancer is its spread throughout the body. The location of a metastatic mass may help to identify the primary tumor. Previous studies have demonstrated that all malignant cervical tumors are metastatic, except for lymphoma. In addition, asymmetric enlargement of one or more cervical lymph nodes in an adult is almost always cancerous and is usually due to metastasis from a primary lesion in the mouth or pharynx [1]. Metastases to head and neck area can occur either from local structures or from distant organs. In most cases, the head and neck region is the primary site for metastasis [2], but metastases may arise from outside of the head and neck region, including the lung, liver, bone, brain, and lymph nodes. Most metastases in the head and neck target the neck lymph nodes [3].

Metastatic tumors of the oral cavity are rare, representing about 1% of oral tumors. They affect the jaws much more frequently than soft tissues [4]. Metastasis to the mandible makes up more than 70% of all malignant metastatic tumors in the oral cavity [5]. To determine the frequency of metastasis to head and neck area, a retrospective study was conducted. The clinical and pathological data are reported here.

Back to Article Outline

2. Materials and methods 

This study was a retrospective review of patients from a University Hospital in Tehran, Iran. During the period 1992 to 2008, records from the Department of Pathology were reviewed with attention to metastatic tumors in head and neck area. Histological confirmation of the metastatic lesion was obtained in 191 cases. The data were analyzed for sex, age, primary site of tumors, metastatic site, and histology of the tumors. For better detailed analysis, the tumors were classified into 2 groups: intraoral and extraoral.

Back to Article Outline

3. Results 

Within the 16-year period of study, a total of 191 cases were found; of these, 118 (62%) were males, and 73 (38%) were females (Table 1). Average age for men was 57.2 years (range, 45–83 years), and for women, 30 years (range, 12–49 years).

Table 1. Distribution of metastatic tumors by sex, age, and location
Variable (191 patients)No. of patients
Sex
Male118
Female73
Age
<153
16-4056
>40132
Tumor primary site
Intraoral site33
Extraoral site158
Lymph node metastases180
Extranodal metastases11

As shown in Table 2 the most common intraoral primary site was tongue (anterior and posterior parts) with 19 cases (9%). According to Table 3, thyroid gland was the most frequent primary extraoral site (n = 59; 30%). The most frequent metastatic site was the lymph node with 180 cases (94%), and level II was the most commonly involved in lymph nodes with 129 cases (67%), followed by level I with 21 cases (10%). Supraclavicular lymph node involvement was detected in 10 cases (5%). Histologically, there was a predominance of squamous cell carcinoma (SCC) (55 cases, 28%) of which 23 cases (12%) developed in oral cavity. Papillary carcinoma with 49 cases (25%) formed the second largest group. The 2 most frequent primary sites histologically diagnosed as SCC were the tongue with 18 cases (9%) and the larynx with 10 cases (5%). Salivary gland metastases developed in 23 cases (12%), of which one was distant metastasis to the brain. Among the salivary glands, submandibular gland was the most commonly found primary site in 12 cases (12%). Lymph node metastases from lesions of salivary glands occurred in 22 cases (11.5%). Metastases to the parotid lymph nodes occurred in 15 cases (7.8%).The dominant histologic type for salivary gland tumors was mucoepidermoid carcinoma (n = 13; 6.8%). Cutaneous metastases occurred in 10 cases (5%). Metastases to the parotid gland (n = 2; 1%) were associated with cutaneous primary malignancies in the head and neck area. Among patients with SCC, level II was the most frequently involved in lymph nodes (n = 39; 20%). The breast, with 4 cases (2%), was the most common primary site with distant metastases, followed by the stomach with 3 cases (1%). The bladder, with 2 cases (1%), was the most frequent site metastasizing to oral cavity, both to buccal mucosa. There was one unknown primary tumor.

Table 2. Distribution of intraoral metastatic tumors by site and type
Primary siteMetastatic siteType of tumorNumber
Posterior tongueLevel IISCC13
Level IISpindle cell tumor1
Anterior tongueLevel ISCC5
Floor of mouthLevel ISCC5
Level IUndifferentiated carcinoma1
Buccal mucosaLevel ISCC2
Level IUndifferentiated carcinoma1
Maxillary alveolusLevel ISCC2
Level IISCC1
PalateLevel IIMucoepidermoid carcinoma1
MandibleLevel IIAmeloblastic carcinoma1
Table 3. Distribution of Extraoral metastatic tumors by site and type
Extraoral primary siteMetastatic siteType of tumorNo. of patients
ThyroidLevel IIPapillary carcinoma49
Level IIMedullary carcinoma3
Level IIAnaplastic carcinoma3
Level IISCC3
Level IIFollicular carcinoma1
NasopharynxLevel IIUndifferentiated carcinoma10
Level IILymphoepithelioma1
Level IISCC1
Level IIIUndifferentiated carcinoma2
Level IIILymphoepithelioma1
LarynxLevel IISCC10
Level IIUndifferentiated carcinoma1
Level IISmall cell carcinoma1
Submandibular glandLevel IIMucoepidermoid carcinoma7
Level IIAdenocarcinoma3
Level IIAdenoid cystic carcinoma1
BrainAdenocarcinoma1
Parotid glandParotid LNMucoepidermoid carcinoma6
Parotid LNAdenoid cystic carcinoma1
Parotid LNCarcinoma ex-pleomorphic adenoma1
Parotid LNMalignant mixed tumor1
Parotid LNSCC1
Maxillary sinusLevel IISCC2
Level IILymphoepithelioma1
Level IIAdenoid cystic carcinoma1
Level IINeuroendocrine carcinoma1
Base of tongueLevel IISCC3
TonsilLevel IISCC1
Level IIUndifferentiated carcinoma1
EsophagusLevel IISCC3
Level IIAdenocarcinoma1
Level IIUndifferentiated carcinoma1
ScalpLevel VMalignant melanoma2
Level VAngiosarcoma1
Parotid LNMalignant melanoma1
BreastSupraclavicular LNDuctal carcinoma2
Skin of neckDuctal carcinoma1
Sella turcicaDuctal carcinoma1
Skin of earParotid LNBasaloid SCC1
ParotidUndifferentiated carcinoma1
ParotidMalignant tricoepithelioma1
StomachSupraclavicular LNAdenocarcinoma2
MandibleAdenocarcinoma1
External auditory canalParotid LNAdenoid cystic carcinoma1
Parotid LNPapillary adenocarcinoma1
BladderBuccal mucosaAdenocarcinoma1
Buccal mucosaTransitional cell carcinoma1
Carotid bodyLevel IParaganglioma2
Lower lipLevel ISCC2
ProstateSupraclavicular LNAdenocarcinoma1
Buccal mucosaAdenocarcinoma1
Skin of neckLevel IISCC2
Skin of parotidParotid LNMalignant melanoma1
Sublingual glandLevel IAdenocarcinoma1
ScrotumSupraclavicular LNMalignant round cell tumor1
RectumSupraclavicular LNUndifferentiated carcinoma1
OvarySupraclavicular LNDysgerminoma1
KidneyBuccal mucosaAdenocarcinoma1
LiverSupraclavicular LNAdenocarcinoma1
LungSupraclavicular LNSmall cell carcinoma1
UnknownCerebellaAdenocarcinoma1

SCC, squamous cell carcinoma; LN, lymph node.

Back to Article Outline

4. Discussion 

Metastasis has been defined as the transfer of disease from one organ or part of an organ to another not directly connected to it. Tumoral cells penetrate into vascular or lymphatic channels, providing the opportunity for spread. Spread is dictated by local anatomy, and each site has its own pattern [6].

In the current study, most of the metastatic tumors to the head and neck region were found in men (n = 118, 62%). Patients were mostly older than 40 years (n = 132, 69%). This finding is in agreement with published reports [1].

In this series, lymph node metastases accounted for 180 cases (94%), of which level II metastases were the most frequent, with 129 cases (67%). Nodal metastases at level I (n = 16) and level II (n = 17) were the most common involved in lymph nodes from intraoral tumors. Level II was the most common lymph node metastasis from extraoral site tumors such as thyroid (n = 59), nasopharynx, and larynx (each 12 cases). Shah found the most common lymph node metastases from oral cavity tumors in level I, II and III, and level II, III and IV lymph nodes were at greatest risk for nodal metastases from the oropharynx, hypopharynx, and larynx [7].

In the present series, involvement of supraclavicular lymph nodes (n = 12) with metastatic cancer occurred due to metastases from infraclavicular sites. This finding is in agreement with previous published reports [3].

In this study, the thyroid gland was the most frequent extraoral primary site with 59 cases (30%), and papillary carcinoma was the most frequent thyroid tumor with 49 cases (25%). By contrast, in one series, the rate of nodal metastases for papillary carcinoma, the most frequent metastatic thyroid tumor, was 50% [8].

In the current series, submandibular gland (n = 12) was the most frequent salivary gland to metastasize to lymph nodes (n = 11), followed by the parotid gland (n = 10), and mucoepidermoid carcinoma was the most frequent histological type (n = 13). These results were similar to those showing that submandibular gland had the highest frequency of lymph node metastases, followed by parotid gland, and mucoepidermoid carcinoma was the most common histologic tumor [8].

Metastasis to the salivary glands is unusual but the parotid is the most common affected site [9]. The present report indicates that metastasis to the parotid gland was noted in 2 cases: one was undifferentiated tumor, and one was malignant trichoepithelioma. This is contrary to previous studies that revealed that SCC was the most frequent histologic tumor metastases to the parotid gland [10].

In the current study, the breast was the most common distant primary site. This finding disagrees with other studies showing the gastrointestinal tract as the most common distant primary site [3].

In this study, the most frequent primary intraoral site was the tongue with 19 cases, followed by the floor of mouth with 6 cases. In the Talmi et al [7] series, the most frequent primary intraoral site was the tongue with 16 cases, followed in frequency by the retromolar trigone with 3 cases.

Here, metastases to the oral cavity were seen in 5; among them, 4 cases developed in oral soft tissues, all to buccal mucosa. This result disagrees with other studies showing that the jaw bones were the most frequent site for intraoral metastases [5] and also that the attached gingival was the most common metastatic site, followed by the tongue [4].

Back to Article Outline

5. Conclusion 

Metastasis is an infrequent finding in head and neck region, and it may represent the initial manifestation of the disease. Diagnostic evaluation of metastatic lesion will detect the primary tumor.

Back to Article Outline

References 

  1. McGuirt WF. Differential diagnosis of neck masses. In:  Cummings ChW,  Flint PW editor. Cummings Otolaryngology Head & Neck Surgery. 2nd ed.. Philadelphia (PA): Elsevier Mosby; 2005;p. 2540–2553
  2. Jones AS, Cook JA, Phillips DE, et al. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer. 1993;72:1756–1761
  3. Imamura SI, Suzuki H. Head and neck metastases from occult abdominal primary site: a case report and literature review. Acta Otolaryngol. 2004;124:107–112
  4. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, et al. Metastatic tumors to the oral cavity: pathogenesis and analysis of 637 cases. Oral Oncol. 2008;44:743–752
  5. Irani S, Moshref M, Lotfi A. Metastasis of a gastric adenocarcinoma to the mandible: a case report. Oral Oncol EXTRA. 2004;40:85–87
  6. McGuirt WF. Differential diagnosis of neck masses. In:  Cummings ChW,  Fredrickson JM editor. 3rd ed.. Otolaryngology head & neck surgery. vol. 3:Philadelphia (PA): Mosby; 1998;p. 1743–1746
  7. Talmi YP, Hoffman HT, Horowitz Z, et al. Patterns of metastases to the upper jugular lymph nodes (the ‘submuscular recess’). Head Neck. 1998;20:682–686
  8. Johns ME, Nachlas NE. Salivary gland tumors. In:  Paparella MM,  Shumrick DA editor. 3rd ed.. Otolaryngology. vol. 3:Philadelphia (PA): Saunders; 1991;p. 2099–2127
  9. Spiegel JH, Brys AK, Bhakti A, et al. Metastasis to the submandibular gland in head and neck carcinomas. Head Neck. 2004;26:1064–1068
  10. Raut V, Sinnathuray AR, Primrose WJ. Aggressive treatment of metastasis to the parotid. Ulster Med J. 2004;73:85–88

PII: S0196-0709(09)00211-7

doi:10.1016/j.amjoto.2009.09.006

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 24-27, January 2011